Bio-Rad Laboratories Inc
Company Profile
Business description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Contact
1000 Alfred Nobel Drive
HerculesCA94547
USAT: +1 510 724-7000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
7,700
Bio-Rad Laboratories Inc News & Analysis
stocks
10 cheap wide-moat US stocks for 2025
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,231.10 | 2.60 | 0.03% |
CAC 40 | 7,717.44 | 7.63 | 0.10% |
DAX 40 | 24,052.86 | 100.01 | -0.41% |
Dow JONES (US) | 45,418.07 | 135.60 | 0.30% |
FTSE 100 | 9,275.99 | 10.19 | 0.11% |
HKSE | 25,201.76 | 323.16 | -1.27% |
NASDAQ | 21,544.27 | 94.98 | 0.44% |
Nikkei 225 | 42,520.27 | 125.87 | 0.30% |
NZX 50 Index | 12,861.84 | 96.14 | -0.74% |
S&P 500 | 6,465.94 | 26.62 | 0.41% |
S&P/ASX 200 | 8,960.50 | 0.70 | -0.01% |
SSE Composite Index | 3,800.35 | 68.03 | -1.76% |